NEKTAR THERAPEUTICS Insider Trading for October 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEKTAR THERAPEUTICS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEKTAR THERAPEUTICS for October 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 11.34 | 83,333 | 944,996 | 250,000 | |
| Oct 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 24.20 | 83,333 | 2,016,659 | 152,504 | 235.8 K to 152.5 K (-35.33 %) |
| Oct 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 11.34 | 83,333 | 944,996 | 235,837 | 152.5 K to 235.8 K (+54.64 %) |
| Oct 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Option Exercise | M | 10.69 | 7,583 | 81,062 | 22,417 | |
| Oct 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Sell | S | 25.00 | 7,583 | 189,575 | 58,233 | 65.8 K to 58.2 K (-11.52 %) |
| Oct 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | Hora Maninder | SVP Pharma Dev & Mf ... | Buy | M | 10.69 | 7,583 | 81,062 | 65,816 | 58.2 K to 65.8 K (+13.02 %) |
| Oct 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Option Exercise | M | 9.53 | 43,677 | 416,242 | 396,323 | |
| Oct 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Sell | S | 24.97 | 43,677 | 1,090,615 | 31,102 | 74.8 K to 31.1 K (-58.41 %) |
| Oct 10 2017 | NKTR | NEKTAR THERAPEUTIC ... | Doberstein Stephen K | SVP & Chief Scienti ... | Buy | M | 9.53 | 43,677 | 416,242 | 74,779 | 31.1 K to 74.8 K (+140.43 %) |
| Oct 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 11.34 | 120,000 | 1,360,800 | 0 | |
| Oct 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 24.45 | 120,000 | 2,934,000 | 63,414 | 183.4 K to 63.4 K (-65.43 %) |
| Oct 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 11.34 | 120,000 | 1,360,800 | 183,414 | 63.4 K to 183.4 K (+189.23 %) |
| Oct 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | M | 11.04 | 56,704 | 626,012 | 313,752 | |
| Oct 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Option Exercise | M | 11.04 | 43,296 | 477,988 | 370,456 | |
| Oct 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 24.21 | 56,704 | 1,372,804 | 41,575 | 98.3 K to 41.6 K (-57.70 %) |
| Oct 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Buy | M | 11.04 | 56,704 | 626,012 | 98,279 | 41.6 K to 98.3 K (+136.39 %) |
| Oct 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Sell | S | 24.04 | 43,296 | 1,040,836 | 41,575 | 84.9 K to 41.6 K (-51.01 %) |
| Oct 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Gergel Ivan P. | SVP & Chief Medical ... | Buy | M | 11.04 | 43,296 | 477,988 | 84,871 | 41.6 K to 84.9 K (+104.14 %) |